Related Experiment Video
Updated: Jun 30, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
PANoptosis-related molecule CASP2 affects the immune microenvironment and immunotherapy response of hepatocellular
Yichao Lou1, Desheng Chen1, Qi Gu1
1Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background:
The involvement of molecules associated with PANoptosis in hepatocellular carcinoma (HCC) is still not well understood.
Methods:
Various R packages were utilized to analyze within the R software. Data that was freely accessible was obtained from the databases of The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC).
Results:
Here, we comprehensively explored the role of PANoptosis-related genes in HCC. The caspase 2 (CASP2) was identified as the interest gene for further analysis. We found that CASP2 is related to the poor prognosis and worse clinical features of HCC patients. Moreover, we explored the biological pathway CASP2 is involved in and found that CASP2 is associated with multiple carcinogenic pathways. Also, we noticed that CASP2 can significantly reshape the HCC immune microenvironment and affect the response rate of immunotherapy. Analysis of drug sensitivity suggested that individuals exhibiting elevated CASP2 levels may display increased susceptibility to doxorubicin and vorinostat while demonstrating resistance towards erlotinib, lapatinib, sunitinib, and temsirolimus. Meanwhile, we explored the single-cell distribution of CASP2 in the HCC microenvironment. To enhance the clinical application of CASP2 in HCC, we constructed a prognosis model using the molecules derived from CASP2, which demonstrated good efficiency in predicting patients prognosis. Moreover, in vitro experiments indicated that CASP2 can significantly inhibits cell proliferation, invasion and migration ability of HCC cells.
Conclusions:
Our study comprehensively explored the role of PANoptosis-related molecule CASP2 in HCC, which can provide directions for future studies.
Insights
This study reveals that Caspase-2 (CASP2), a PANoptosis-related molecule, is linked to poor prognosis in hepatocellular carcinoma (HCC). CASP2 influences the tumor microenvironment, immunotherapy response, and drug sensitivity, offering new therapeutic directions.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- The role of PANoptosis-related molecules in hepatocellular carcinoma (HCC) remains largely uncharacterized.
- Understanding these molecular players is crucial for developing novel therapeutic strategies against HCC.
Purpose of the Study:
- To comprehensively investigate the involvement of PANoptosis-related genes in HCC.
- To identify and analyze the specific role of Caspase-2 (CASP2) in HCC progression and patient outcomes.
Main Methods:
- Utilized R packages for data analysis of publicly available datasets from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC).
- Performed comprehensive bioinformatic analyses, including pathway enrichment, immune microenvironment assessment, drug sensitivity analysis, and single-cell distribution analysis of CASP2.
- Constructed a prognostic model based on CASP2-derived molecules and validated findings through in vitro experiments.
Main Results:
- Caspase-2 (CASP2) was identified as a key molecule associated with poor prognosis and adverse clinical features in HCC patients.
- CASP2 is implicated in multiple carcinogenic pathways, significantly alters the HCC immune microenvironment, and impacts immunotherapy response.
- Elevated CASP2 levels correlate with differential sensitivity to specific chemotherapeutic agents and targeted therapies.
- In vitro studies demonstrated that CASP2 inhibits HCC cell proliferation, invasion, and migration.
Conclusions:
- This study elucidates the multifaceted role of the PANoptosis-related molecule CASP2 in hepatocellular carcinoma.
- CASP2 serves as a potential prognostic biomarker and therapeutic target in HCC, influencing tumor progression and treatment response.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway